Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oramed Pharmaceuticals (ORMP) Operating Margin (2022 - 2025)

Oramed Pharmaceuticals (ORMP) has disclosed Operating Margin for 3 consecutive years, with 1201.15% as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Operating Margin rose 176361.0% year-over-year to 1201.15%, compared with a TTM value of 1498.36% through Dec 2024, up 267515.0%, and an annual FY2024 reading of 1498.36%, up 267515.0% over the prior year.
  • Operating Margin was 1201.15% for Q2 2024 at Oramed Pharmaceuticals, up from 500.34% in the prior quarter.
  • Across five years, Operating Margin topped out at 1201.15% in Q2 2024 and bottomed at 1693.92% in Q2 2022.
  • Average Operating Margin over 3 years is 698.82%, with a median of 991.36% recorded in 2022.
  • The sharpest move saw Operating Margin surged 90751bps in 2023, then soared 176361bps in 2024.
  • Year by year, Operating Margin stood at 1363.5% in 2022, then surged by 59bps to 562.46% in 2023, then soared by 314bps to 1201.15% in 2024.
  • Business Quant data shows Operating Margin for ORMP at 1201.15% in Q2 2024, 500.34% in Q1 2024, and 562.46% in Q2 2023.